Singapore markets closed

Danimer Scientific, Inc. (DNMR)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
0.8767+0.0718 (+8.92%)
At close: 04:00PM EDT
0.8673 -0.01 (-1.07%)
Pre-market: 07:04AM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-155,473
-155,473
-179,758
-60,107
-8,853
Depreciation & amortisation
29,058
29,058
20,086
10,634
5,123
Deferred income taxes
-199
-199
-814
-13,233
0
Stock-based compensation
56,035
56,035
56,958
55,270
3,645
Change in working capital
13,502
13,502
-19,321
-29,398
-7,181
Accounts receivable
4,184
4,184
-3,056
-11,359
-1,600
Inventory
6,481
6,481
-11,170
-9,799
-6,604
Accounts payable
-635
-635
-1,565
2,048
993
Other working capital
-74,949
-74,949
-226,323
-248,374
-52,065
Other non-cash items
9,957
9,957
2,166
951
2,464
Net cash provided by operating activities
-47,264
-47,264
-61,837
-62,963
-13,797
Cash flows from investing activities
Investments in property, plant and equipment
-27,685
-27,685
-164,486
-185,411
-38,268
Acquisitions, net
0
0
-14
-151,179
0
Other investing activities
-
-
-18,037
-
-
Net cash used for investing activities
-27,663
-27,663
-182,482
-336,168
-38,259
Cash flows from financing activities
Debt repayment
-13,030
-13,030
-1,504
-27,162
-1,941
Common stock issued
225
225
-
-
32,518
Common stock repurchased
-
-
-236
-890
0
Other financing activities
-33,446
-33,446
-1,800
-47,192
382,011
Net cash used provided by (used for) financing activities
84,030
84,030
21,752
306,202
422,675
Net change in cash
9,103
9,103
-222,567
-92,929
370,619
Cash at beginning of period
64,401
64,401
286,968
379,897
9,278
Cash at end of period
73,504
73,504
64,401
286,968
379,897
Free cash flow
Operating cash flow
-47,264
-47,264
-61,837
-62,963
-13,797
Capital expenditure
-27,685
-27,685
-164,486
-185,411
-38,268
Free cash flow
-74,949
-74,949
-226,323
-248,374
-52,065